# MIRECULE, INC.: A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy  and other Neuromuscular Disorders

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | MIRECULE, INC. |
| Location | Gaithersburg, MD |
| Project | A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy  and other Neuromuscular Disorders |
| Project number | 5R44NS119147-05 |
| Mechanism | R44 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $608,751 |
| Awarded | 2026-09-04 |
| Project period | 2021-09-20 to 2027-08-31 |
| UEI | D2DDKPAALJR3 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11393057). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.